The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 19, 2024

Filed:

Sep. 23, 2022
Applicant:

Shire Human Genetic Therapies, Inc., Lexington, MA (US);

Inventors:

Bronislava Gedulin, Del Mar, CA (US);

Michael Grey, Rancho Santa Fe, CA (US);

Niall O'Donnell, Encinitas, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 13/12 (2006.01); A61K 31/155 (2006.01); A61K 31/38 (2006.01); A61K 31/40 (2006.01); A61K 31/4436 (2006.01); A61K 31/4453 (2006.01); A61K 31/454 (2006.01); A61K 31/495 (2006.01); A61K 31/4995 (2006.01); A61K 31/5377 (2006.01); A61K 31/554 (2006.01); A61K 31/7028 (2006.01); A61K 31/7042 (2006.01); A61K 45/06 (2006.01); A61P 1/16 (2006.01); A61P 43/00 (2006.01); C07C 257/10 (2006.01); C07C 279/12 (2006.01); C07D 207/04 (2006.01); C07D 211/06 (2006.01); C07D 211/08 (2006.01); C07D 281/10 (2006.01); C07D 285/36 (2006.01); C07D 295/13 (2006.01); C07D 337/08 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); C07D 487/08 (2006.01); C07H 15/18 (2006.01); C07H 15/26 (2006.01);
U.S. Cl.
CPC ...
C07H 13/12 (2013.01); A61K 31/155 (2013.01); A61K 31/38 (2013.01); A61K 31/40 (2013.01); A61K 31/4436 (2013.01); A61K 31/4453 (2013.01); A61K 31/454 (2013.01); A61K 31/495 (2013.01); A61K 31/4995 (2013.01); A61K 31/5377 (2013.01); A61K 31/554 (2013.01); A61K 31/7028 (2013.01); A61K 31/7042 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 43/00 (2018.01); C07C 257/10 (2013.01); C07C 279/12 (2013.01); C07D 207/04 (2013.01); C07D 211/06 (2013.01); C07D 211/08 (2013.01); C07D 281/10 (2013.01); C07D 285/36 (2013.01); C07D 295/13 (2013.01); C07D 337/08 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01); C07D 487/08 (2013.01); C07H 15/18 (2013.01); C07H 15/26 (2013.01); Y02A 50/30 (2018.01);
Abstract

Provided herein are methods of treating or ameliorating hypercholemia or a cholestatic liver disease by administering to an individual in need thereof a therapeutically effective amount of an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. Also provided are methods for treating or ameliorating a liver disease, decreasing the levels of serum bile acids or hepatic bile acids, treating or ameliorating pruritis, reducing liver enzymes, or reducing bilirubin comprising administering to an individual in need thereof a therapeutically effective amount of ASBTI or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…